Analyticon Biotechnologies AG’s Recent Addition, Hemolyzer 5NG Aims to Offer Efficient Hematology Test Outcome


Published on : Jan 18, 2019

Albany, New York, January 18, 2019: Analyticon Biotechnologies AG, an offshoot of Analyticon Discovery GmbH is a prominent name in the gamut of medical devices and diagnostics. Lack of apt medical aid owing to incompetent diagnostic systems continue to plague medical fraternity. Analyticon Biotechnologies boasts of state-of-the-art diagnostic portfolio comprising urine diagnostics, hematology, clinical chemistry and coagulation. The company also demonstrates a promising foothold in support and consulting services with a diverse end-user portfolio inclusive of hospitals and clinical laboratories. This research report by Market Research Hub (MRH) under the title, ‘Analyticon Biotechnologies AG - Product Pipeline Analysis, 2018 Update’ sheds light on new products and services by Analyticon Biotechnologies AG. 

Prevalence of Gene Anomalies Fuels Analyticon Biotechnologies AG’s Hematology Device Portfolio

Prevalence of genetic anomalies besides critical medical conditions such as cancers, diabetes, infections, and anemia have prompted adoption of hematology tests to diagnose potential disease triggers. To further accentuate hematology tests, Analyticon Biotechnologies AG continues to invest in product innovations to remain industry specific.

To achieve this objective, Analyticon Biotechnologies AG has recently diversified and enhanced its hematology device offerings with new, Hemolyzer 5NG. The product has been designed to offer user-friendly interface to facilitate microfluidic analysis at minimal sample volume. The product owing to its sleek dimensions is expected to fare effectively in emergency room and lab settings besides ensuring cost effective performance.

Analyticon Biotechnologies AG Product Pipeline: Report Scope

This elaborate research report on pipeline review of Analyticon Biotechnologies AG commences with an elaborate snapshot encompassing vital details on dynamics and trends that influence Analyticon Biotechnologies AG’s investment strategies. Further, the report assesses Analyticon Biotechnologies AG’s market position on the basis of crucial parameters such as its company overview, company facts and developments, product portfolio, range of diagnostic services, as well as recent developments in terms of strategic acquisitions, mergers, and new product launch.

Further in the course of the report, readers are also presented with vital market information on Analyticon Biotechnologies AG’s geographical footprint, employee structure and subsidiaries. In-depth understanding on Analyticon Biotechnologies AG’s existing portfolio as well as pipeline diagnostic services is aimed at offering report readers with ample competitive advantage besides enlightening readers with entry level barriers based on which aspiring market entrants as well as established entities can aptly deliver lucrative business decisions and investment plans to secure a leading stance amidst stiffening competition. By geography, Analyticon Biotechnologies AG has significant presence in Europe, Asia-Pacific, Americas, and Middle East. In terms of product type,

By segments, Analyticon Biotechnologies AG's product pipeline is classified by equipment type, indication, development stage, and trial status. Further, the report also evaluates each of the pipeline product on the basis of pipeline territory, development stage, regulatory protocol, device class, applications as well as indications, besides including information on launch date estimations. Further, a dedicated chapter on clinical trials encompassing trial name, objective, design, and status has also been documented in the report to derive actionable business insights on product pipeline of Analyticon Biotechnologies AG.

Competitive Landscape: Analyticon Biotechnologies AG Product Pipeline

In its trailing sections the report also includes crucial details on existing competitive spectrum, highlighting potent competitors along with their company overview, portfolio diversification, winning tactical strategies, as well as recent developments in terms of new product addition, buy-outs, as well as strategic coalitions and product pipeline with their respective status and launch date.

Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=2027920

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top